Showing results (1101-1110 of 3,105) with videos related to
Sort By:
Pageof 311
Drug Safety|November 24, 2004
Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an exampleMargaret A Honein, Cynthia A Moore, J David EricksonDrug Safety|March 24, 2005
Benefit-risk assessment of zaleplon in the treatment of insomniaJoseph Barbera, Colin ShapiroDrug Safety|March 24, 2005
Vitex agnus castus: a systematic review of adverse eventsClaudia Daniele, Joanna Thompson Coon, Max H Pittler, et al.Drug Safety|March 24, 2005
Safety profile of different low-molecular weight heparins used at therapeutic doseIsabelle Gouin-Thibault, Eric Pautas, Virginie SiguretDrug Safety|February 5, 2005
Drugs, QT interval prolongation and ICH E14: the need to get it rightRashmi R ShahDrug Safety|April 28, 2005
Potential determinants of drug-drug interaction associated dispensing in community pharmaciesMatthijs L Becker, Marjon Kallewaard, Peter W J Caspers, et al.Drug Safety|April 28, 2005
Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trialsVincent T Andriole, Daniel C Haverstock, Shurjeel H ChoudhriDrug Safety|December 14, 2004
Benefit-risk assessment of the levonorgestrel intrauterine system in contraceptionTiina BackmanDrug Safety|February 4, 2006
Interactions between antiepileptic and antipsychotic drugsFrank M C Besag, David BerryDrug Safety|January 26, 2008
Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and managementWilliam P Cheshire, Robert D FealeyPageof 311